All countries, N = 19,601 | Gender | Age | Education | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Women | Men | p-valueb | 18–34 | 35–54 | 55+ | p-valueb | Secondary or less | Tertiary | p-valueb | |
N | 9,583 | 10,018 | 5,753 | 7,975 | 5,873 | 12,163 | 7,438 | |||
Cancer | 57% | 49% | < 0.001 | 56% | 53% | 49% | < 0.001 | 47% | 62% | < 0.001 |
Heart disease | 71% | 64% | < 0.001 | 74% | 68% | 61% | < 0.001 | 64% | 73% | < 0.001 |
Liver disease | 93% | 86% | < 0.001 | 89% | 91% | 89% | < 0.001 | 88% | 93% | < 0.001 |
Respiratory disease | 12% | 11% | < 0.001 | 15% | 11% | 9% | < 0.001 | 10% | 13% | < 0.001 |
Don’t know | 4% | 7% | < 0.001 | 6% | 5% | 6% | 0.001 | 6% | 3% | < 0.001 |
None | 1% | 3% | < 0.001 | 1% | 1% | 3% | < 0.001 | 2% | 1% | 0.098 |
Female breast cancer* | 21% | 10% | < 0.001 | 15% | 16% | 14% | 0.004 | 10% | 23% | < 0.001 |
Liver cancer* | 54% | 46% | < 0.001 | 53% | 50% | 47% | < 0.001 | 45% | 59% | < 0.001 |
Colon cancer* | 42% | 35% | < 0.001 | 38% | 41% | 36% | < 0.001 | 33% | 48% | < 0.001 |
Oral cancer* | 31% | 25% | < 0.001 | 30% | 29% | 24% | < 0.001 | 23% | 36% | < 0.001 |
Skin cancer* | 7% | 5% | 0.001 | 10% | 5% | 3% | < 0.001 | 5% | 8% | < 0.001 |
Don’t know* | 1% | 2% | 0.009 | 2% | 2% | 1% | 0.040 | 2% | 2% | 0.598 |
None* | 0% | 0% | 0.084 | 0% | 0% | 0% | 0.013 | 0% | 0% | 0.178 |